BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 24580813)

  • 1. Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions.
    Marcus JL; Buisker T; Horvath T; Amico KR; Fuchs JD; Buchbinder SP; Grant RM; Liu AY
    HIV Med; 2014 Aug; 15(7):385-95. PubMed ID: 24580813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
    Songtaweesin WN; Kawichai S; Phanuphak N; Cressey TR; Wongharn P; Saisaengjan C; Chinbunchorn T; Janyam S; Linjongrat D; Puthanakit T;
    J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25564. PubMed ID: 32869511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying Best Practices for Increasing HIV Pre-exposure Prophylaxis (PrEP) Use and Persistence in the United States: A Systematic Review.
    Kamitani E; Higa DH; Crepaz N; Wichser M; Mullins MM;
    AIDS Behav; 2024 Jul; 28(7):2340-2349. PubMed ID: 38743381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.
    Okwundu CI; Okoromah CA
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007189. PubMed ID: 19160329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges.
    Krakower DS; Mayer KH
    Drugs; 2015 Feb; 75(3):243-51. PubMed ID: 25673022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
    Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.
    Haberer JE; Baeten JM; Campbell J; Wangisi J; Katabira E; Ronald A; Tumwesigye E; Psaros C; Safren SA; Ware NC; Thomas KK; Donnell D; Krows M; Kidoguchi L; Celum C; Bangsberg DR
    PLoS Med; 2013; 10(9):e1001511. PubMed ID: 24058300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-exposure Prophylaxis Uptake, Adherence, and Persistence: A Narrative Review of Interventions in the U.S.
    Garrison LE; Haberer JE
    Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S73-S86. PubMed ID: 34686294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of Oral Pre-exposure Prophylaxis HIV Adherence Interventions.
    Haines M; Vandyk A; Skidmore B; Orser L; O'Byrne P
    J Assoc Nurses AIDS Care; 2024 Jul-Aug 01; 35(4):309-324. PubMed ID: 38564213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Evans C; Hoverman A; Sun C; Dana T; Bougatsos C; Grusing S; Korthuis PT
    JAMA; 2019 Jun; 321(22):2214-2230. PubMed ID: 31184746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials.
    Amico KR; Mansoor LE; Corneli A; Torjesen K; van der Straten A
    AIDS Behav; 2013 Jul; 17(6):2143-55. PubMed ID: 23435697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough Acute HIV Infections among Pre-Exposure Prophylaxis Users with High Adherence: A Narrative Review.
    Moschese D; Lazzarin S; Colombo ML; Caruso F; Giacomelli A; Antinori S; Gori A
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.
    Okwundu CI; Uthman OA; Okoromah CA
    Cochrane Database Syst Rev; 2012 Jul; (7):CD007189. PubMed ID: 22786505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review.
    Bradley E; Forsberg K; Betts JE; DeLuca JB; Kamitani E; Porter SE; Sipe TA; Hoover KW
    J Womens Health (Larchmt); 2019 Sep; 28(9):1272-1285. PubMed ID: 31180253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social Support Networks Among Young Men and Transgender Women of Color Receiving HIV Pre-Exposure Prophylaxis.
    Wood S; Dowshen N; Bauermeister JA; Lalley-Chareczko L; Franklin J; Petsis D; Swyryn M; Barnett K; Weissman GE; Koenig HC; Gross R
    J Adolesc Health; 2020 Mar; 66(3):268-274. PubMed ID: 31672523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
    Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
    AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of adherence to oral pre-exposure prophylaxis for HIV - how can we improve uptake and adherence?
    Sidebottom D; Ekström AM; Strömdahl S
    BMC Infect Dis; 2018 Nov; 18(1):581. PubMed ID: 30445925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.